Neumora Therapeutics, Inc. — Investor Relations & Filings

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to redefining neuroscience drug development. The company focuses on creating precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. Neumora utilizes its proprietary 'Precision Toolbox,' an integrated data science platform, to identify patient subtypes and develop targeted therapies with novel mechanisms of action. This approach aims to address the significant unmet medical needs in brain health by applying the principles of precision medicine. The company's pipeline includes navacaprant, a clinical-stage candidate for the treatment of Major Depressive Disorder (MDD).